Tiantan bio

Haizheng pharmaceutical and Junshi biology signed a contract for commissioned production of Xinguan oral drug vv116

Heavy bomb in the field of hypoglycemic! Lilly tirzepatide approved for listing

Academician Pan Yi and Professor Shen Bairong joined the Weiwei science and technology strategy committee

Roche PD-L1 combined with tigit failed in the first-line treatment of stage III non-small cell lung cancer with high expression of PD-L1

Foreign media said Green Valley pharmaceutical Alzheimer's disease new drug phase IX phase I ® The international phase III clinical trial has been stopped

The new drug registration of step pharmaceutical subsidiary was terminated, and 7.6 million R & D expenses have been invested

Pfizer acquired biohaven for about US $11.6 billion to expand the product pipeline of nervous system diseases

Medtronic's world's first self expanding pulmonary valve was first-class recalled

Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use

The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.

Nanomicro Technology: first release of a new product of protein A affinity chromatography medium

It is said that Yin Xiyue will not send special envoys to China, Russia and Japan, but only to the United States and the European Union

Guangdong Securities Regulatory Bureau issued a warning letter to Zhengzhong Zhujiang certified public accountants

Five departments including the central bank: encourage financial institutions to incorporate the application of open source technology into their informatization development plans

Annual report of Shanghai Hong Kong Group: net profit in 2020 decreased by 8.33% year-on-year, and it is planned to pay 1.28 yuan for 10 shares